1388 CRB-601, an integrin αvβ8 blocking antibody entering phase I: pre-clinical and translational biomarkers for indication selection

• Daqing Wang,
• Maneesh Singh,
• Ian Hodgson,
• Danish Memon,
• Vaishali Shinde,
• Rachael Brake,
• Andrew Kolodziej,
• James Rindone,
• Rodney Carter,
• Naomi Muse

Affiliations

Daqing Wang

Corbus Pharmaceuticals, Norwood, MA, USA

Maneesh Singh

1Corbus Pharmaceuticals, Inc., Norwood, MA, USA

Ian Hodgson

Corbus Pharmaceuticals, Norwood, MA, USA

Danish Memon

1Corbus Pharmaceuticals, Inc., Norwood, MA, USA

Vaishali Shinde

Corbus Pharmaceuticals, Norwood, MA, USA

Rachael Brake

1Corbus Pharmaceuticals, Inc., Norwood, MA, USA

Andrew Kolodziej

1Corbus Pharmaceuticals, Inc., Norwood, MA, USA

James Rindone

Corbus Pharmaceuticals, Norwood, MA, USA

Rodney Carter

Corbus Pharmaceuticals, Norwood, MA, USA

Naomi Muse

Corbus Pharmaceuticals, Norwood, MA, USA